Biblio
“Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.”, Alzheimers Dement, vol. 12, no. 2, pp. 121-129, 2016.
, “Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.”, Mol Psychiatry, vol. 20, no. 12, pp. 1588-95, 2015.
, “Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.”, Neurobiol Dis, vol. 21, no. 2, pp. 256-75, 2006.
, “Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.”, Am J Med Genet B Neuropsychiatr Genet, vol. 124B, no. 1, pp. 29-37, 2004.
, “Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.”, Am J Med Genet B Neuropsychiatr Genet, vol. 136B, no. 1, pp. 62-8, 2005.
, “Genetic association between endothelial nitric oxide synthase and Alzheimer disease.”, Clin Genet, vol. 70, no. 1, pp. 49-56, 2006.
, “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.
, “Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.”, Am J Hum Genet, vol. 83, no. 5, pp. 623-32, 2008.
, “Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.”, J Med Genet, vol. 42, no. 10, pp. 787-92, 2005.
, “Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.”, Neuromolecular Med, vol. 5, no. 2, pp. 133-46, 2004.
, “Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.”, Acta Neuropathol, vol. 105, no. 5, pp. 484-8, 2003.
, “Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.”, Neuromolecular Med, vol. 5, no. 2, pp. 133-46, 2004.
, “Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.”, Hum Mol Genet, vol. 24, no. 12, pp. 3557-70, 2015.
, “Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.”, Am J Hum Genet, vol. 73, no. 5, pp. 1041-51, 2003.
, “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.
, “Association of apolipoprotein E genotype and Alzheimer disease in African Americans.”, Arch Neurol, vol. 63, no. 3, pp. 431-4, 2006.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.”, Mol Psychiatry, vol. 9, no. 11, pp. 1042-51, 2004.
, “ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.”, PLoS One, vol. 12, no. 7, p. e0177814, 2017.
, “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.”, Ann Neurol, vol. 59, no. 1, pp. 21-6, 2006.
, “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
, “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.
,